WRAIR, Clinical Trials Center

Silver Spring, Maryland 20910-7500

0 studies enrolling now · 10 studies all time

What they study most

Dengue, Dengue Fever, Dengue Virus, Hantaan Virus, Malaria, Falciparum, Marburg Virus Disease, Plague Vaccine, Plasmodium Vivax Malaria, SARS-CoV-2 Infection, Vaccine Reaction

Studies at this site

• PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 — Completed
• A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults — Status unconfirmed
• cAd3-Marburg Vaccine in Healthy Adults — Completed
• Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine — Status unconfirmed
• A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine — Completed
• Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant — Completed
• Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults — Completed
• A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults — Completed
• Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in Humans — Completed
• Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S — Completed